Two Orthogonal Approaches to Overcome Multi-Drug Resistant HIV-1s: Development of Protease Inhibitors and Entry Inhibitors Based on CXCR4 Antagonists

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|4|2|103-110

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.4, Iss.2, 2004-06, pp. : 103-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 protease inhibitors in development

By Catamancio Simona La Seta   Rusconi Stefano  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 387-395

Informa Healthcare

Access to resources Recommend Favorite

Tipranavir: a protease inhibitor for multi-drug resistant HIV-1

By Best Brookie   Haubrich Richard  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 59-70

Informa Healthcare

Access to resources Recommend Favorite

Approaches to the Design of Effective HIV-1 Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 7, Iss. 4, 2000-04 ,pp. : 455-477

Bentham Science Publishers

Access to resources Recommend Favorite

Current Development on HIV-1 Protease Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 3, Iss. 3, 2007-09 ,pp. : 201-213

Bentham Science Publishers

Access to resources Recommend Favorite